Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: PaxMedica Inc. PXMD

MissionIRNewsBreaks – Why PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’

Posted on September 22, 2023 by MissionIR

PaxMedica (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”) for the treatment of autism spectrum disorder (“ASD”) and other serious conditions with intractable neurologic symptoms. “The company’s lead programs are focused … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment

PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’

Posted on September 13, 2023 by MissionIR

PaxMedica (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms. The company’s lead programs are focused … Continue reading →

Posted in PaxMedica Inc. PXMD | Leave a comment